Apollo Medical Holdings Inc
NASDAQ:ASTH

Watchlist Manager
Apollo Medical Holdings Inc Logo
Apollo Medical Holdings Inc
NASDAQ:ASTH
Watchlist
Price: 36.28 USD -4.45% Market Closed
Market Cap: $1.8B

Wall St Price Targets

ASTH Price Targets Summary
Apollo Medical Holdings Inc

Wall Street analysts forecast ASTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASTH is 46.92 USD with a low forecast of 41.41 USD and a high forecast of 52.5 USD.

Lowest Forecast
Price Target
41.41 USD
14% Upside
Average Forecast
Price Target
46.92 USD
29% Upside
Highest Forecast
Price Target
52.5 USD
45% Upside
Apollo Medical Holdings Inc Competitors:
Price Targets
COHU
Cohu Inc
53% Upside
ABSI
Absci Corp
92% Upside
SRFM
Surf Air Mobility Inc
604% Upside
SIGI
Selective Insurance Group Inc
-2% Downside

Revenue
Forecast

42% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
42% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 4 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 6 years is 11%.

Gross Profit
Forecast

18% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
18% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 4 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 21%.

Operating Income
Forecast

0% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
0% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 4 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 6 years is 25%.

Pre-Tax Income
Forecast

-16% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
-16% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -16%. The projected CAGR for the next 3 years is 71%.

Net Income
Forecast

-24% / Year
Past Growth
79% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
-24% / Year
Past Growth
79% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 4 years, the compound annual growth rate for Net Income has been -24%. The projected CAGR for the next 3 years is 79%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ASTH's stock price target?
Price Target
46.92 USD

According to Wall Street analysts, the average 1-year price target for ASTH is 46.92 USD with a low forecast of 41.41 USD and a high forecast of 52.5 USD.

What is the Revenue forecast for Apollo Medical Holdings Inc?
Projected CAGR
11%

Over the last 4 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 6 years is 11%.

What is the Gross Profit forecast for Apollo Medical Holdings Inc?
Projected CAGR
21%

Over the last 4 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 21%.

What is the Operating Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
25%

Over the last 4 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 6 years is 25%.

What is the Pre-Tax Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
71%

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -16%. The projected CAGR for the next 3 years is 71%.

What is the Net Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
79%

Over the last 4 years, the compound annual growth rate for Net Income has been -24%. The projected CAGR for the next 3 years is 79%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett